212 related articles for article (PubMed ID: 11517321)
1. The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination.
Rasmussen IB; Lunde E; Michaelsen TE; Bogen B; Sandlie I
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10296-301. PubMed ID: 11517321
[TBL] [Abstract][Full Text] [Related]
2. CD40/APC-specific antibodies with three T-cell epitopes loaded in the constant domains induce CD4+ T-cell responses.
Rasmussen IB; Oynebråten I; Høydahl LS; Flobakk M; Lunde E; Michaelsen TE; Bogen B; Sandlie I
Protein Eng Des Sel; 2012 Mar; 25(3):89-96. PubMed ID: 22233931
[TBL] [Abstract][Full Text] [Related]
3. Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells.
Lunde E; Munthe LA; Vabø A; Sandlie I; Bogen B
Nat Biotechnol; 1999 Jul; 17(7):670-5. PubMed ID: 10404160
[TBL] [Abstract][Full Text] [Related]
4. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
[TBL] [Abstract][Full Text] [Related]
5. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules.
Sexton A; Whitney PG; Chong SF; Zelikin AN; Johnston AP; De Rose R; Brooks AG; Caruso F; Kent SJ
ACS Nano; 2009 Nov; 3(11):3391-400. PubMed ID: 19824668
[TBL] [Abstract][Full Text] [Related]
6. Breaking of B cell tolerance toward a highly conserved self protein.
Dalum I; Jensen MR; Hindersson P; Elsner HI; Mouritsen S
J Immunol; 1996 Dec; 157(11):4796-804. PubMed ID: 8943381
[TBL] [Abstract][Full Text] [Related]
7. Bystander help within a polyepitope DNA vaccine improves immune responses to influenza antigens.
Baird M; Wilson R; Young L; Williman J; Young S; Wilson M; Slobbe L; Lockhart E; Buchan G
Scand J Immunol; 2004 Oct; 60(4):363-71. PubMed ID: 15379861
[TBL] [Abstract][Full Text] [Related]
8. MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.
Ilkovitch D; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2004 Jun; 53(6):525-32. PubMed ID: 14730400
[TBL] [Abstract][Full Text] [Related]
9. Recombinant antibodies for delivery of antigen: a single loop between beta-strands in the constant region can accommodate long, complex and tandem T cell epitopes.
Tunheim G; Schjetne KW; Rasmussen IB; Sollid LM; Sandlie I; Bogen B
Int Immunol; 2008 Mar; 20(3):295-306. PubMed ID: 18252695
[TBL] [Abstract][Full Text] [Related]
10. Specific T cell lines for ovalbumin, ovomucoid, lysozyme and two OA synthetic epitopes, generated from egg allergic patients' PBMC.
Holen E; Elsayed S
Clin Exp Allergy; 1996 Sep; 26(9):1080-8. PubMed ID: 8889264
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
Robson NC; Donachie AM; Mowat AM
Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
[TBL] [Abstract][Full Text] [Related]
12. Amino acid residues distinct from the determinant region can profoundly affect activation of T cell clones by related antigens.
Shastri N; Miller A; Sercarz EE
J Immunol; 1986 Jan; 136(2):371-6. PubMed ID: 2416804
[TBL] [Abstract][Full Text] [Related]
13. Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes.
Tunheim G; Schjetne KW; Fredriksen AB; Sandlie I; Bogen B
J Leukoc Biol; 2005 Mar; 77(3):303-10. PubMed ID: 15576418
[TBL] [Abstract][Full Text] [Related]
14. Branched polypeptides as antigens for influenza virus hemagglutinin and T-cell receptor subunits.
Tóth GK; Váradi G; Nagy Z; Monostori E; Penke B; Hegedüs Z; Andó I; Fazekas G; Kurucz I; Mák M
Pept Res; 1993; 6(5):272-80. PubMed ID: 8257803
[TBL] [Abstract][Full Text] [Related]
15. Self and foreign 60-kilodalton heat shock protein T cell epitope peptides serve as immunogenic carriers for a T cell-independent sugar antigen.
Könen-Waisman S; Fridkin M; Cohen IR
J Immunol; 1995 Jun; 154(11):5977-85. PubMed ID: 7538539
[TBL] [Abstract][Full Text] [Related]
16. Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer.
Galili U
Cancer Immunol Immunother; 2004 Nov; 53(11):935-45. PubMed ID: 15205919
[TBL] [Abstract][Full Text] [Related]
17. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.
Sloots A; Mastini C; Rohrbach F; Weth R; Curcio C; Burkhardt U; Jäger E; Forni G; Cavallo F; Wels WS
Clin Cancer Res; 2008 Nov; 14(21):6933-43. PubMed ID: 18980988
[TBL] [Abstract][Full Text] [Related]
19. Peptidomimics of antigen are present in variable region of heavy and light chains of anti-idiotypic antibody and function as surrogate antigen for perpetuation of immunological memory.
Vani J; Justin J; Nagasuma RC; Nayak R; Shaila MS
Mol Immunol; 2007 Jul; 44(13):3345-54. PubMed ID: 17408744
[TBL] [Abstract][Full Text] [Related]
20. Induction of differential T-cell epitope by plain- and liposome-coupled antigen.
Taneichi M; Tanaka Y; Kasai M; Mori M; Nishida M; Yamamura H; Mizuguchi J; Uchida T
Bioconjug Chem; 2006; 17(4):899-904. PubMed ID: 16848395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
